These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7793128)

  • 1. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation.
    Kaashoek MJ; Moerman A; Madić J; Weerdmeester K; Maris-Veldhuis M; Rijsewijk FA; van Oirschot JT
    Vaccine; 1995 Mar; 13(4):342-6. PubMed ID: 7793128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle.
    Van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Weerdmeester K; Rijsewijk FA
    J Virol Methods; 1997 Aug; 67(1):23-34. PubMed ID: 9274815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine.
    Bosch JC; Kaashoek MJ; van Oirschot JT
    Vaccine; 1997 Oct; 15(14):1512-7. PubMed ID: 9330461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
    Kaashoek MJ; van Oirschot JT
    Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
    Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
    Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines.
    Bosch JC; Kaashoek MJ; Kroese AH; van Oirschot JT
    Vet Microbiol; 1996 Oct; 52(3-4):223-34. PubMed ID: 8972048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
    Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
    Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of latent bovine herpesvirus 1 in cattle seronegative to glycoproteins gB and gE.
    Hage JJ; Glas RD; Westra HH; Maris-Veldhuis MA; Van Oirschot JT; Rijsewijk FA
    Vet Microbiol; 1998 Feb; 60(2-4):87-98. PubMed ID: 9646441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against bovine herpesvirus (BHV) 5 may be differentiated from antibodies against BHV1 in a BHV1 glycoprotein E blocking ELISA.
    Wellenberg GJ; Mars MH; Van Oirschot JT
    Vet Microbiol; 2001 Jan; 78(1):79-84. PubMed ID: 11118743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
    Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
    Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-linked immunosorbent assays.
    Wellenberg GJ; Verstraten ER; Mars MH; Van Oirschot JT
    J Clin Microbiol; 1998 Feb; 36(2):409-13. PubMed ID: 9466750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.